RRoche Read More Roche Gets FDA Approval for Another Label Expansion of Tecentriq2026-10-10 Roche RHHBY has secured yet another label expansion for its cancer immunotherapy Tecentriq (atezolizumab) in the United States.…
RRoche Read More Roche Gets FDA Approval for Another Label Expansion of Tecentriq2026-10-09 Roche RHHBY has secured yet another label expansion for its cancer immunotherapy Tecentriq (atezolizumab) in the United States.…
RRoche Read More Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study2026-05-30 Roche Holding shares fell after the company said a late-stage study for an experimental breast-cancer treatment missed its…
RRoche Read More Will Roche Stock Rebound To Its 2022 Highs of $50?2026-03-29 The stock price of Roche (OTCMKTS: RHHBY) trades at $35 per share, about 33% below its peak level of over…